Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$13.50 – $21.22
14% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $575.99B | $590.59B | $556.91B | $729.97B | $951.25B | $1.02T | $1.06T | $1.12T |
| Cost of revenue | $396.51B | $401.15B | $374.81B | $489.67B | $621.93B | $690.73B | $689.39B | $751.94B |
| Gross profit | $179.48B | $189.44B | $182.10B | $240.29B | $329.32B | $331.80B | $372.24B | $372.53B |
| Gross margin | 31.2% | 32.1% | 32.7% | 32.9% | 34.6% | 32.4% | 35.1% | 33.1% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $36.03B | $37.56B | $31.53B | $41.41B | $62.28B | $75.70B | $82.08B | $86.12B |
| EBITDA | $45.62B | $47.50B | $41.29B | $56.27B | $85.80B | $103.67B | $106.56B | $109.93B |
| Net income | $25.04B | $26.18B | $21.60B | $34.38B | $40.55B | $52.35B | $54.67B | $56.13B |
| Net margin | 4.3% | 4.4% | 3.9% | 4.7% | 4.3% | 5.1% | 5.2% | 5.0% |
| EPS (diluted) | 60.02 | 84.98 | 70.12 | 93.78 | 95.99 | 125.27 | 133.81 | 140.61 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $1.17T | $152.10 | $149.79–$155.69 | 1 |
| 2028 | $1.20T | $161.97 | $159.51–$165.80 | 1 |
| 2029 | $1.24T | $170.97 | $168.37–$175.01 | 1 |
| 2030 | $1.29T | $202.45 | $199.37–$207.23 | 1 |
Forward consensus · source: Financial Modeling Prep
MATSUMOTOKIYOSHI HLDG ORD
No one on the platform currently holds MSMKF.
No tracked institution reports a position in MSMKF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-31 | $28.0000 | |
| 2026-09-30 | $28.0000 | |
| 2026-03-31 | $26.0000 | 2026-06-22 |
| 2025-09-30 | $24.0000 | 2025-12-02 |
| 2025-03-31 | $23.0000 | 2025-06-23 |
| 2024-09-30 | $21.0000 | 2024-12-03 |
| 2024-03-28 | $20.0000 | 2024-06-24 |
| 2023-09-29 | $50.0000 | 2023-12-04 |
| Execution date | Ratio |
|---|---|
| 2023-09-28 | 3-for-1 |
No one on the platform has traded MSMKF yet.
| +0.00% |
| $6.6B |
| — |
| SHTDYSinopharm Group Co. Ltd. | $10.26 | -0.39% | $6.4B | — |
| SKHCFSonic Healthcare Limited | $12.76 | +0.00% | $6.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.